Company intelligence / Profile preview

Zymergen

Emeryville, California, United Statessec.gov ↗

Ownership: Private
Employees: ~45
Development stage: Commercial

Overview

Zymergen developed an advanced synthetic biology platform integrating automation, machine learning/artificial intelligence (AI), and genomics to engineer microbes for the production of novel molecules used in industries such as pharmaceuticals, agriculture, materials science/electronics. The company did not have traditional drug candidates but instead offered a technology stack to accelerate biological discovery and manufacturing innovation. It filed for bankruptcy in October 2023 after being acquired by Ginkgo Bioworks in late 2022.

Therapeutic areas: Other
Modalities: Engineered microbes/strainsSynthetic biology platforms
Industry: Non-Drug Biotech

Drug pipeline

1 asset

Hyaline

Commercial

Indications: Electronics display film

Partnerships

Notable partnerships with Fortune 500 companies across agriculture/chemicals/materials/pharma sectors; specifics not detailed but included collaborative development agreements.

Beyond the preview

Go deeper on Zymergen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zymergen.

Explore the full profile